Aberrant ARID5B expression and its association with Ikaros dysfunction in acute lymphoblastic leukemia

about

Aberrant ARID5B expression and its association with Ikaros dysfunction in acute lymphoblastic leukemia

Item

http://www.wikidata.org/entity/Q58690864

description

scientific article published on 12 November 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2018

@uk

name

Aberrant ARID5B expression and ...... n acute lymphoblastic leukemia

@en

Aberrant ARID5B expression and ...... n acute lymphoblastic leukemia

@nl

type

Item

label

Aberrant ARID5B expression and ...... n acute lymphoblastic leukemia

@en

Aberrant ARID5B expression and ...... n acute lymphoblastic leukemia

@nl

prefLabel

Aberrant ARID5B expression and ...... n acute lymphoblastic leukemia

@en

Aberrant ARID5B expression and ...... n acute lymphoblastic leukemia

@nl

P1476

Aberrant ARID5B expression and ...... n acute lymphoblastic leukemia

@en

P2093

Guofeng Gao

http://www.w3.org/2001/XMLSchema#string

Jinlong Ma

http://www.w3.org/2001/XMLSchema#string

Justin Sloane

http://www.w3.org/2001/XMLSchema#string

Laszlo Szekely

http://www.w3.org/2001/XMLSchema#string

Qi Han

http://www.w3.org/2001/XMLSchema#string

Qinyu Ge

http://www.w3.org/2001/XMLSchema#string

Sinisa Dovat

http://www.w3.org/2001/XMLSchema#string

Yan Gu

http://www.w3.org/2001/XMLSchema#string

Zheng Ge

http://www.w3.org/2001/XMLSchema#string

P2860

Confirmation of childhood acute lymphoblastic leukemia variants, ARID5B and IKZF1, and interaction with parental environmental exposures

PKA-dependent regulation of the histone lysine demethylase complex PHF2-ARID5B

Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia.

ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia.

Protein phosphatase 1 (PP1) and Casein Kinase II (CK2) regulate Ikaros-mediated repression of TdT in thymocytes and T-cell leukemia.

Association of genetic variation in IKZF1, ARID5B, and CEBPE and surrogates for early-life infections with the risk of acute lymphoblastic leukemia in Hispanic children.

ARID5B, IKZF1 and non-genetic factors in the etiology of childhood acute lymphoblastic leukemia: the ESCALE study.

Characterization of LEF1 High Expression and Novel Mutations in Adult Acute Lymphoblastic Leukemia

Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome

Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia.

P2888

s41389-018-0095-x

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41389-018-0095-X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Chunhua Song

Kimberly J Payne

P577

2018-11-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30420689

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

cancer research

molecular biology

P932

6232140

http://www.w3.org/2001/XMLSchema#string